Cancer patients warned to avoid unauthorised ‘miracle cure’

The Health Products Regulatory Authority (HPRA), formerly known as the Irish Medicines Board, has issued the warning on Globulin component Macrophage Activating Factor (GcMAF) following concerns that the product is being imported to Ireland to treat cancer patients.
Proponents of the blood product claim it can be used to treat cancer, HIV, and autism.